Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Clinical differences in pediatric CKD patients with and without left ventricular diastolic dysfunctionVariablePatients with left ventricular diastolic dysfunction (n = 11)Patients without left ventricular diastolic dysfunction (n = 233)P valueAge, median (full range)7.6 (0.5 to 13.0)11.4 (0.3 to 17.9)0.037Male/Female6/5162/710.325Chronic kidney disease stage I4 (36.4)41 (17.6) II3 (27.3)44 (18.9) III2 (18.2)83 (35.6) IV2 (18.2)43 (18.5) V: 22 (9.4)Height Z-score−1.2 ± 1.0−0.8 ± 1.60.445Weight Z-score−1.1 ± 1.1−0.8 ± 1.80.332Body mass index Z-score−0.3 ± 1.2−0.3 ± 1.40.861Estimated glomerular filtration rate (ml/min/1.73 m2)76.7 ± 46.056.5 ± 37.70.117Hypertension6 (66.7)151 (71.6)0.718Hemoglobin (g/dL)11.1 ± 1.812.4 ± 1.80.015Transferrin Saturation (%)27.6 ± 21.127.8 ± 13.00.589Serum albumin (g/dL)4.1 ± 0.44.1 ± 0.60.353Serum Ca (mg/dL)9.2 ± 0.59.5 ± 0.70.062Serum P (mg/dL)4.8 ± 0.54.8 ± 0.90.944Ca x P (mg2/dL2)43.9 ± 5.445.5 ± 8.50.456Serum tCO2 (mmol/L)23.3 ± 3.822.5 ± 3.50.715Total cholesterol (mg/dL)154.3 ± 20.7184.5 ± 70.40.054Serum low-density lipoprotein cholesterol (mg/dL)95.0 ± 17.2106.1 ± 63.50.888Serum high-density lipoprotein cholesterol (mg/dL)46.3 ± 11.954.4 ± 15.00.077Serum triglyceride (mg/dL)108.6 ± 37.5153.5 ± 158.90.347Intact parathyroid hormone (pg/mL)49.8 (17.1 to 243.0)55.3 (5.8 to 1244.0)0.92625 (OH) vitamin D3 (ng/mL)26.0 ± 17.321.1 ± 9.20.452Tubular reabsorption of phosphate (%)90.5 ± 8.377.6 ± 13.70.009Left ventricular mass index (g/m2.7)48.8 ± 14.936.5 ± 12.70.002left ventricular wall thickness z-score1.4 ± 3.7−3.1 ± 6.30.008Data are presented as the mean ± standard deviation, as the median with the full range given in the parentheses, or as the number of patients with the percentage given in parentheses

Source: Clinical difference between patients with and without LVDD. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A total of 244 patients were included in the final analysis.

Source: Abstract.

We used the baseline data of the KoreaN cohort study for Outcome in patients With Pediatric Chronic Kidney Disease (KNOW-Ped CKD), a nationwide, 10-year, prospective, observational cohort study of pediatric CKD.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study

Cohort study · BMC Nephrology · 2020

Original publication title

Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study

Jeong Yeon Kim; Yeonhee Lee; Hee Gyung Kang; Il-Soo Ha; Hae Il Cheong; Hyun Jin Choi; Kyoung Hee Han; Seong Heon Kim; Min Hyun Cho; Jae Il Shin; Joo Hoon Lee; Young Seo Park; Heeyeon Cho

© The Author(s) 2020

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study shows that LVH patients have a greater risk of LVDD and that anemia is the only modifiable risk factor for LVDD in Korean pediatric CKD patients.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Cardiovascular disease (CVD) is the most common cause of mortality in pediatric chronic kidney disease (CKD) patients. Left ventricular (LV) hypertrophy (LVH) is associated with LV diastolic dysfunction (LVDD) development and is used as an early marker of CVD in pediatric CKD. This study aimed to assess the prevalence and risk factors of LVDD and the association between LVH and LVDD in Korean pediatric CKD patients.

Source: Background

Abstract: What methods does the paper describe?

Data were collected using the baseline data of the Korean cohort study for outcome in patients with pediatric chronic kidney disease, a nationwide, 10-year, prospective, observational cohort study of pediatric CKD. A total of 244 patients were included in the final analysis. Two-dimensional echocardiography and tissue Doppler images were used to evaluate LVH and LVDD. LVH was defined as an LV mass index (LVMI) ≥38 g/m2.7 and LV-wall thickness z-score > 1.64. LVDD was defined as a mitral peak velocity of early filling to early diastolic mitral annular velocity (E/E’) > 14.

Univariate and multivariate logistic regression analyses were performed to evaluate risk factors of LVDD.

Source: Methods

Abstract: Results

In this study, the male-to-female ratio was 2.2 (168:76) and median age was 11.2 years. The average estimated glomerular filtration rate was 57.4 ml/min/1.73 m2, and no patients received renal replacement therapy. The mean value of LVMI and E/E’ was 37.0 g/m2.7 and 7.4, respectively. The prevalence of LVH was 40.1 and 17.4% by LVMI ≥38 g/m2.7 and LV-wall thickness z-score, respectively. The prevalence of LVDD was 4.5%, and patients with LVH showed greater risk of LVDD (odds ratio 7.3, p = 0.012).

In the univariate analysis, young age, low hemoglobin level, higher LVMI, and higher LV-wall thickness z-score were associated with LVDD. In the multivariate analysis, young age, low hemoglobin level, and higher LV-wall thickness z-score were independently associated with LVDD.

Source: Results

Abstract: Conclusion

This study shows that LVH patients have a greater risk of LVDD and that anemia is the only modifiable risk factor for LVDD in Korean pediatric CKD patients.

Source: Conclusion
Authors’ abstract

Background

Cardiovascular disease (CVD) is the most common cause of mortality in pediatric chronic kidney disease (CKD) patients. Left ventricular (LV) hypertrophy (LVH) is associated with LV diastolic dysfunction (LVDD) development and is used as an early marker of CVD in pediatric CKD. This study aimed to assess the prevalence and risk factors of LVDD and the association between LVH and LVDD in Korean pediatric CKD patients.

Methods

Data were collected using the baseline data of the Korean cohort study for outcome in patients with pediatric chronic kidney disease, a nationwide, 10-year, prospective, observational cohort study of pediatric CKD. A total of 244 patients were included in the final analysis. Two-dimensional echocardiography and tissue Doppler images were used to evaluate LVH and LVDD. LVH was defined as an LV mass index (LVMI) ≥38 g/m2.7 and LV-wall thickness z-score > 1.64. LVDD was defined as a mitral peak velocity of early filling to early diastolic mitral annular velocity (E/E’) > 14.

Univariate and multivariate logistic regression analyses were performed to evaluate risk factors of LVDD.

Results

In this study, the male-to-female ratio was 2.2 (168:76) and median age was 11.2 years. The average estimated glomerular filtration rate was 57.4 ml/min/1.73 m2, and no patients received renal replacement therapy. The mean value of LVMI and E/E’ was 37.0 g/m2.7 and 7.4, respectively. The prevalence of LVH was 40.1 and 17.4% by LVMI ≥38 g/m2.7 and LV-wall thickness z-score, respectively. The prevalence of LVDD was 4.5%, and patients with LVH showed greater risk of LVDD (odds ratio 7.3, p = 0.012).

In the univariate analysis, young age, low hemoglobin level, higher LVMI, and higher LV-wall thickness z-score were associated with LVDD. In the multivariate analysis, young age, low hemoglobin level, and higher LV-wall thickness z-score were independently associated with LVDD.

Conclusion

This study shows that LVH patients have a greater risk of LVDD and that anemia is the only modifiable risk factor for LVDD in Korean pediatric CKD patients.

Publication and source details

Original title: Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study

Jeong Yeon Kim; Yeonhee Lee; Hee Gyung Kang; Il-Soo Ha; Hae Il Cheong; Hyun Jin Choi; Kyoung Hee Han; Seong Heon Kim; Min Hyun Cho; Jae Il Shin; Joo Hoon Lee; Young Seo Park; Heeyeon Cho

BMC Nephrology · 2020

© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100003669Korea Centers for Disease Control and Prevention2016E3300201Ha Il-Soo

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T13:52:57.494317+00:00

DOI: 10.1186/s12882-020-02152-6 · PMC7724800